CoChat
Cited by 220

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome

Open access
Huang, Yi, Ma, Chunling, Zhang, Qunyuan, Ye, Jian, Wang, Fang, Zhang, Yanping, Hunborg, Pamela, Varvares, Mark A., Hoft, Daniel F., Hsueh, Eddy C., Peng, Guangyong · 2015 · Oncotarget

Abstract

// Yi Huang 1,2,* , Chunling Ma 1,3,4,* , Qunyuan Zhang 5 , Jian Ye 1 , Fang Wang 1,6 , Yanping Zhang 7 , Pamela Hunborg 7 , Mark A. Varvares 8 , Daniel F. Hoft 1 , Eddy C. Hsueh 7 and Guangyong Peng 1 1 Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO, USA 2 Center for Clinical Molecular Medicine, Children’s Hospital of Chongqing Medical University, Chongqing, P. R. China 3 Department of Laboratory Medicine, Women and Children’s Health Care Hospital of Linyi City, Linyi, P. R. China 4 Molecular Biology Experimental Center, Shandong Medical College, Linyi, P. R. China 5 Department of Genetics, Washington University School of Medicine in St. Louis, Saint Louis, MO, USA 6 Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, P. R. China 7 Department of Surgery, Saint Louis University School of Medicine, Saint Louis, MO, USA 8 Department of Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine, Saint Louis, MO, USA * These authors are contributed equally to this work Correspondence to: Eddy C. Hsueh, email: // Guangyong Peng, email: // Keywords : CD4 + T cells; CD8 + T cells; regulatory T cells; Th17 cells; breast tumor microenvironment Received : February 11, 2015 Accepted : April 09, 2015 Published : April 29, 2015 Abstract The Cancer Immunoediting concept has provided critical insights suggesting dual functions of immune system during the cancer initiation and development. However, the dynamics and roles of CD4 + and CD8 + T cells in the pathogenesis of breast cancer remain unclear. Here we utilized two murine breast cancer models (4T1 and E0771) and demonstrated that both CD4 + and CD8 + T cells were increased and involved in immune responses, but with distinct dynamic trends in breast cancer development. In addition to cell number increases, CD4 + T cells changed their dominant subsets from Th1 in the early stages to Treg and Th17 cells in the late stages of the cancer progression. We also analyzed CD4 + and CD8 + T cell infiltration in primary breast cancer tissues from cancer patients. We observed that CD8 + T cells are the key effector cell population mediating effective anti-tumor immunity resulting in better clinical outcomes. In contrast, intra-tumoral CD4 + T cells have negative prognostic effects on breast cancer patient outcomes. These studies indicate that CD4 + and CD8 + T cells have opposing roles in breast cancer progression and outcomes, which provides new insights relevant for the development of effective cancer immunotherapeutic approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.3958

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 220

Metadata

Authors
Huang, Y., Ma, C., Zhang, Q., Ye, J., Wang, F., Zhang, Y., Hunborg, P., Varvares, M. A., Hoft, D. F., Hsueh, E. C., & Peng, G.
Venue
Oncotarget
Published
2015-04-29
Volume
6
Issue
19
Pages
17462-17478
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2137018390
Cited by
220
References
9
FWCI
6.73
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome. https://app.cochat.ai/papers/10.18632/oncotarget.3958
The paper
Huang, Y., Ma, C., Zhang, Q., Ye, J., Wang, F., Zhang, Y., Hunborg, P., Varvares, M. A., Hoft, D. F., Hsueh, E. C., & Peng, G. (2015). CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome. Oncotarget. https://doi.org/10.18632/oncotarget.3958

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.